期刊文献+

胃原发性Burkitt淋巴瘤的护理要点分析

Analysis on critical nursing experiences in management of primary gastric Burkitt lymphoma
原文传递
导出
摘要 目的:探究胃原发性Burkitt淋巴瘤的护理要点及存在问题。方法:回顾性分析2005年9月~2012年6月普外科收治的胃原发性Burkitt淋巴瘤11例患者的临床资料与护理资料。结果:患者平均住院时长46天,随访10~44个月,化疗完全缓解率为90.1%(10/11),3年无事件生存率81.8%(9/11),复发率9.1%(1/11),死亡率9.1%(1/11)。结论:护理人员应注意增强患者免疫力、严格防止肿瘤崩解综合征的发生,可提高患者生活质量。 Objective:To explore the critical nursing experiences in management of primary gastric Burkitt lymphomas.Methods:Retrospectively analyzed the clinical data of 11 patients who were admitted to this hospital for primary gastric Burkitt lymphomas and re-ceived treatment during September 20051 and June 2012.Results:The mean time was 46 days when patients were in hospital.In the fol-low-up of 10~44 months, the complete remission rate was 90.1%(10/11), event-free survival (EFS) of three years were 81.8%(10/11), reoccurring rate was 9.1%(10/11), the death rate was 9.1%(10/11), cases of ependymomas did not reoccur, and 11.1%cases cured completely.Conclusion:A better prognosis would be attained when given strictly strengthening patients'immunity, and pre-venting from tumour lysis syndrome .
作者 何利 李雪莲
出处 《中国伤残医学》 2015年第18期34-36,共3页 Chinese Journal of Trauma and Disability Medicine
关键词 BURKITT淋巴瘤 护理 Gastric Burkitt lymphoma Nursing
  • 相关文献

参考文献22

  • 1Colovi6 N, Radovanovi6 N, Vidovi6 A, et al. Primary Burkitt's lymphoma of the stomach] [J]. Srp Arh Celok Lek, 2011, 139 (7 -8) :523 -6.
  • 2Johnson JK, Sorensen E. Critical care issues in management of high -grade lymphoma[ J]. Crit Care Nuts Clin North Am, 2013, 25 (4) :447 - 57.
  • 3Ngoma T, Adde M, Durosinmi M, et al. Treatment of Burkitt lym- phoma in equatorial Africa using a simple three - drug combination followed by a salvage regimen for patients with persistent or recur- rent disease[J]. Br J Haematol, 2012, 158(6) :749 -62.
  • 4Bayraktar UD, Ramos JC, Petrich A,et al. Outcome of patients with relapsed/refractory acquired immune deficiency syndrome related lymphoma diagnosed 1999 - 2008 and treated with curative intent in the AIDS Malignancy Consortium[ J]. Leuk Lymphoma, 2012, 53 (12) :2383 -9.
  • 5Ahmad N, Zaidi A, Badar F, et al. Clinical characteristics and out- come analysis of pediatric B - cell non - Hodgkin lymphoma. Ex- perience with FAB - LMB 96 and UKCCSG B - cell NHL guide- lines in a developing country[J]. Asia Pac J Clin Oncol, 2010, 6 (1) :49 -56.
  • 6Padmanabhan MY, Pandey RK, Kumar A, et al. Dental manage- ment of a pediatric patient with Burkitt lymphoma: a ease report [J]. Spee Care Dentist, 2012, 32(3) :118 -23.
  • 7Mbulaiteye SM. Burkitt Lymphoma : beyond discoveries [ J 3. Infect Agent Cancer, 2013, 8( 1 ) :35.
  • 8Traor6 F, Core C, Atteby JJ, et al. Cyclophospharnide monotherapy in children with Burkitt lymphoma: a study from the French - Afri- ean Pediatric Oneology Group (GFAOP) [ J ]. Pediatr Blood Cane-er, 2011, 56(1):70-6.
  • 9Buckle GC, Collins JP, Sumba PO, et al. Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lympho- ma among children inUganda and westem Kenya: a cross - sectional survey[Jl. Infect Agent Cancer, 2013, 8(1) :36.
  • 10Earley A. Sustainability not all that matters: lessons fi'omCameroon [J]. Arch Dis Child, 2010, 95(11) :928 -30.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部